In both trials, the most common adverse events were nausea, vomiting, diarrhea, and constipation
This means semaglutide clears more slowly and has a longer effective duration per dose
This personalized approach reduces rebound risk
Patients searching for advanced weight-loss options in Connecticut are often looking for more than generic information
When covered by Aetna, Zepbound is typically listed under their Preferred Brand (PB) drug tier
Additionally, while clinical guidelines for indicated use of GLP-1 RAs are rapidly changing as evidence for GLP-1 RA use evolves, the ethics of off-label use are particularly important to consider given the impact these shortages can have on access for patients who otherwise have a strong clinical indication to be on them